Matinas BioPharma Holdings, Inc. (MTNB) financial statements and ratios from SEC XBRL: revenue $1.10M (TTM), net margin -2093.2%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.10M |
| Net Margin | -2093.2% |
| Price / Book | 0.70 |
| Sector P/E (Healthcare) | 21.7 |
MTNB overview · MTNB earnings · MTNB KPIs · MTNB investor relations · MTNB ownership · MTNB peers · MTNB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.